AbemaciclibAPIメーカーとサプライヤー | CAS 1231929-97-7 - Dr. Reddy's
世界のトップAPIメーカーおよびサプライヤー企業から、抗がん/腫瘍の下にあるOral Solid/Tabletsおよび合成を使用してAbemaciclib API(CAS No. 1231929-97-7)の見積もりをオンラインで入手してください。
seen from Germany
seen from China
seen from Australia

seen from United States
seen from Austria
seen from Italy

seen from Singapore

seen from United States

seen from China

seen from Malaysia

seen from United States
seen from Türkiye
seen from United States
seen from China
seen from Malaysia
seen from United States
seen from South Korea

seen from United States
seen from China
seen from China
AbemaciclibAPIメーカーとサプライヤー | CAS 1231929-97-7 - Dr. Reddy's
世界のトップAPIメーカーおよびサプライヤー企業から、抗がん/腫瘍の下にあるOral Solid/Tabletsおよび合成を使用してAbemaciclib API(CAS No. 1231929-97-7)の見積もりをオンラインで入手してください。
Get a quote of Abemaciclib API (CAS No. 1231929-97-7) with Oral Solid/Tablets dose form & Synthetic API technology under Anti-Cancer/ Oncolo
Abemaciclib Fabricante y proveedor de API | CAS 1231929-97-7 - Dr. Reddy's
https://api.drreddys.com/es/productos/abemaciclib
Obtenga una cita de Abemaciclib API (CAS No. 1231929-97-7) con Oral Solid/Tablets y Sintético en Anti-Cáncer / Oncologico en línea de la principal compañía global de fabricantes y proveedores de API.
Abemaciclib Fabricante e Fornecedor da API | CAS 1231929-97-7 - Dr. Reddy's
Obtenha uma cotação de Abemaciclib API (CAS No. 1231929-97-7) com Oral Solid/Tablets e Sintético em Anti-Câncer / Oncologia on -line da prin
Obtenha uma cotação de Abemaciclib API (CAS No. 1231929-97-7) com Oral Solid/Tablets e Sintético em Anti-Câncer / Oncologia on -line da principal empresa global de API e empresa de fornecedores.
Abemaciclib is a type of drug called a selective cyclin-dependent kinase (CDK) inhibitor. It specifically targets and inhibits the activity
Abemaciclib API
Abemaciclib API is the active pharmaceutical ingredient (API) in the cancer drug Verzenio. It is a selective cyclin-dependent kinase (CDK) inhibitor that works by blocking the activity of certain CDK enzymes. CDKs are involved in cell division and growth, so blocking their activity can slow down or stop the growth of cancer cells.
Abemaciclib API is used to treat several types of cancer, including breast cancer, advanced non-small cell lung cancer (NSCLC), and metastatic colorectal cancer (mCRC). It is taken orally and is typically used in combination with other cancer drugs.
Abemaciclib API is manufactured by several companies, including Qingmu Pharmaceutical, Seqens, and Porton Pharma Solutions. It is available in different dosage forms, including capsules and tablets.
Here are some additional details about Abemaciclib API:
CAS number: 1231929-97-7
Molecular formula: C20H23N7O3
Molecular weight: 427.45 g/mol
Physical description: White to off-white powder
Solubility: Soluble in dimethyl sulfoxide (DMSO) and slightly soluble in water
Abemaciclib API is a potent drug and should only be used under the supervision of a qualified healthcare professional.